Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Feb 5.
doi: 10.1111/cup.70068. Online ahead of print.

PD-L1-Inhibitor-Associated Hidradenitis Suppurativa

Annie Jin  1 , Katherine T Steele  1 , Emily Y Chu  1
Affiliations

PD-L1-Inhibitor-Associated Hidradenitis Suppurativa

Annie Jin et al. J Cutan Pathol. .
No abstract available

Keywords: PD‐L1; cutaneous adverse reaction; hidradenitis suppurativa; immune checkpoint inhibitor.

PubMed Disclaimer

References

    1. J. Bonigen, C. Raynaud‐Donzel, J. Hureaux, et al., “Anti‐PD1‐Induced Psoriasis: A Study of 21 Patients,” Journal of the European Academy of Dermatology and Venereology 31, no. 5 (2017): e254–e257, https://doi.org/10.1111/jdv.14011.
    1. N. Malviya, I. W. Tattersall, J. Leventhal, and A. Alloo, “Cutaneous Immune‐Related Adverse Events to Checkpoint Inhibitors,” Clinics in Dermatology 38, no. 6 (2020): 660–678, https://doi.org/10.1016/j.clindermatol.2020.06.011.
    1. V. Ravi, N. J. Maloney, and S. Worswick, “Neutrophilic Dermatoses as Adverse Effects of Checkpoint Inhibitors: A Review,” Dermatologic Therapy 32, no. 5 (2019): e13074, https://doi.org/10.1111/dth.13074.
    1. O. Lamberg, K. Pandher, and N. H. Matthews, “Nivolumab‐Induced Hidradenitis Suppurativa: A Case Report,” Dermatology Online Journal 30, no. 4 (2024): 3, https://doi.org/10.5070/D330464106.
    1. A. Maillard, D. Pastor, and R. Merat, “Anti‐PD‐1‐Induced Hidradenitis Suppurativa,” Dermatopathology (Basel) 8, no. 1 (2021): 37–39, https://doi.org/10.3390/dermatopathology8010007.

LinkOut - more resources